Michael Diem, MD

Dr. Michael Diem joined Amicus Therapeutics in September 2017 as Senior Vice President, Business and Corporate Development. He brings many years of global experience in the pharmaceutical and biotechnology industries as well academic and clinical medicine. Prior to Amicus: Senior Vice President of Corporate and Business Development at Aevi Genomic Medicine, Global Head of Corporate Strategy and Corporate Development for AstraZeneca, Head of Business Development for GSK Rare Diseases, Partner in GSK’s corporate venture capital firm, SR One, Limited, and practiced medicine for six years.  Degrees:  BA in Biol. Sci. from Rutgers Univ., MD from Rutgers-RWJMS, MBA from Case Western Reserve Univ.  Medical training: Duke Univ., and is a Kauffman Fellow. Mike is currently a Board Director at VenatoRx Pharmaceuticals and is a member of the board of governors of the Boys and Girls Clubs of Philadelphia.